Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Outcome of Patients with Advanced Hodgkin Lymphoma Who Are Either Refractory to or Relapsed After Primary Therapy with the Stanford V Regimen

Lauren S. Maeda, MD, Richard T. Hoppe, MD, Saul A. Rosenberg, MD, Sandra J. Horning, MD, Ranjana H. Advani, MD

Blood (2010) 116 (21): 4828.

https://doi.org/10.1182/blood.V116.21.4828.4828

Published: 2010

Journal Articles

Role of FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience.

Lauren S Maeda, MD, Sandra J Horning, MD, Andrei H Iagaru, MD, Frank I Lin, MD, Richard T Hoppe, MD, Saul A Rosenberg, MD, Ranjana H Advani, MD

Blood (2009) 114 (22): 1563.

https://doi.org/10.1182/blood.V114.22.1563.1563

Published: 2009

Journal Articles

Stage I/II Hodgkin’s Disease: Comparison of Outcomes of Patients with Bulky Mediastinal Disease Versus Other Risk Factors; the Stanford V Experience.

Ranjana H. Advani, MD, Richard T. Hoppe, MD, Saul A. Rosenberg, MD, Sandra J. Horning, MD

Blood (2007) 110 (11): 2316.

https://doi.org/10.1182/blood.V110.11.2316.2316

Published: 2007

Journal Articles

Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.

Daryl Tan, MD, Saul A. Rosenberg, MD, Ronald Levy, MD, Philip Lavori, PhD, Robert Tibshirani, PhD, Richard T. Hoppe, MD, Roger Warnke, MD, Ranjana Advani, MD, Yasodha Natkunam, MD, Alan Yuen, MD, Sandra J. Horning, MD

Blood (2007) 110 (11): 3428.

https://doi.org/10.1182/blood.V110.11.3428.3428

Published: 2007

Journal Articles

Assessment of Favorable (F) Versus Unfavorable (U) Early Stage Hodgkin’s Disease (HD); the Stanford V + Radiotherapy (RT) Experience.

Ranjana Advani, MD, Lauren Maeda, Richard T. Hoppe, MD, Sheila Breslin, RN, Saul A. Rosenberg, MD, David Baer, MD, Joseph Mason, MD, Sandra J. Horning, MD

Blood (2005) 106 (11): 1932.

https://doi.org/10.1182/blood.V106.11.1932.1932

Published: 2005

Journal Articles

Efficacy and Late Effects of Stanford V Chemotherapy and Radiotherapy in Untreated Hodgkin’s Disease: Mature Data in Early and Advanced Stage Patients.

Sandra J. Horning, MD, Richard T. Hoppe, MD, Ranjana Advani, MD, Roger Warnke, MD, David Baer, MD, Joseph Mason, MD, Saul A. Rosenberg, MD

Blood (2004) 104 (11): 308.

https://doi.org/10.1182/blood.V104.11.308.308

Published: 2004

NARROW

Outcome of Patients with Advanced Hodgkin Lymphoma Who Are Either Refractory to or Relapsed After Primary Therapy with the Stanford V Regimen

Role of FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience.

Stage I/II Hodgkin’s Disease: Comparison of Outcomes of Patients with Bulky Mediastinal Disease Versus Other Risk Factors; the Stanford V Experience.

Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.

Assessment of Favorable (F) Versus Unfavorable (U) Early Stage Hodgkin’s Disease (HD); the Stanford V + Radiotherapy (RT) Experience.

Efficacy and Late Effects of Stanford V Chemotherapy and Radiotherapy in Untreated Hodgkin’s Disease: Mature Data in Early and Advanced Stage Patients.

Email alerts

ASH Publications

American Society of Hematology

Outcome of Patients with Advanced Hodgkin Lymphoma Who Are Either Refractory to or Relapsed After Primary Therapy with the Stanford V Regimen

Role of FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience.

Stage I/II Hodgkin’s Disease: Comparison of Outcomes of Patients with Bulky Mediastinal Disease Versus Other Risk Factors; the Stanford V Experience.

Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.

Assessment of Favorable (F) Versus Unfavorable (U) Early Stage Hodgkin’s Disease (HD); the Stanford V + Radiotherapy (RT) Experience.

Efficacy and Late Effects of Stanford V Chemotherapy and Radiotherapy in Untreated Hodgkin’s Disease: Mature Data in Early and Advanced Stage Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only